Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune... by David B Weiner, Donald O’Rourke, Kevin Liaw, Pratik S Bhojnagarwala, Devivasha Bordoloi, Daniel H Park, Nicholas J Tursi, Shushu Zhao, Zev A Binder

Get full text